Newsletter | August 25, 2021

08.25.21 -- Identifying The "X" Factors To Maximize Your Outsourcing Success

Eliminate Drug Discovery Errors Before They Happen – Why Picking The Correct Binding Technology Is Critical To Success

Starting with the right tool is crucial in saving you time and money in the drug development process. This toolbox covers Temperature Related Intensity Change (TRIC), Surface Plasmon Resonance (SPR), Differential Scanning Fluorimetry (DSF), and Isothermal Titration Calorimetry (ITC).

Leverage High-Throughput Assays And 3D Cell Culture High Content Screening For Sharper Insights

Due to the spherical nature of 3D cell culture, one can detect resistance to compounds that 2D cultures are incapable of capturing, thus eliminating the likelihood of false positives and inaccurate IC50 determinations.

Immuno-Oncology Testing Results – Lymphoma Mouse Model A20 Shows Sensitivity To Check Point Inhibitors

One of the most encouraging areas of research for emerging new therapeutics is immunotherapy. In this study, the A20 cell line was derived from a B lymphocyte reticulum cell sarcoma originally isolated from an old BALB/c mouse.

"From Benches to Batches" - What You Need To Seamlessly Transition from Clinical to Commercial

Ryan Downey, Director of Customer Operations, Commercial Development with more than two decades of experience bringing drug products from formulation to finished dose, offers insights into the essential capabilities your CDMO must have to meet your project timeline – and why August Bioservices is rapidly becoming one of the most sought-after and fastest-growing CDMOs in the industry.